Noreen Schuck joins Dynamic42 as new lab assistant
We are excited to announce that Noreen Schuck has joined us at the beginning of October to support our lab team.
With a growing demand for our organ-on-chip models as well, biochips Dynamic42 is eager to expand their lab team, therefore Noreen did join us at just the right time.
In 2017, Noreen completed her Bachelor at the University of Jena in biochemistry followed by a master’s in chemical biology which she completed in 2020. Initially, Noreen worked at Synlab as a lab assistant on Sars-CoV-2 virus diagnosis before she moved on to work at the Leibniz Institute for Natural Product Research and Infection Biology in Jena.
We are delighted that Noreen has now decided to join Dynamic42 to continue her work in organ chips which she already started during her master’s thesis at Prof. Lilienfeld-Toal research group at the University Hospital Jena.
Here is what she has to say:
I got to know the organ-on-chip model during my master thesis, and now I am excited I can join the team of Dynamic42 to keep working with the fascinating complex 3D cell culture models. Also, the ethical aspect to help reduce animal experiences is a great motivation to work with these.
You can connect with Noreen or learn more about our organ-on-a-chip platforms here.
Read more News:
ATHANA alliance for antifungal therapy approaches – First strategy workshop
The RUBIN alliance “ATHANA” met for their first strategy workshop one year after the project kicked off in summer last year.
Cancer, rheumatism, asthma: organ-on-chip models highly relevant for preclinical testing of therapeutic antibodies
Improving people’s lives with innovative technologies. This was the goal that Jena-based Dynamic42 had in mind 18 months ago when they launched a project – funded as part of the Sanofi iDEA-iTECH Award Program.
Amélie Marie Paillereau joins Dynamic42 as Master Student funded by the Thuringia and European Social Fund Plus
We are excited to welcome Amélie Marie Paillereau to the Dynamic42 science team. Amélie started in April with us for a 12-month-long Master thesis, focusing on perfused breast and pancreatic cancer-on-chip models to study the impact of the tumor microenvironment on immune cell invasion.